the earliest the product could launch is probably mid 2015, they have plenty of time and would be wise to not hire too many people prior to approval. Or, a sale would be fine with me.
I prefer they spend time getting their application filing correct, that's the only key job they need to focus on other than lining up potential partners and lining up new employees to hire for the launch, which should be very slow and careful to keep the burn/risk down in case of an unexpected delay.
Never buy ARNA calls except for long tern, in the money as a stock replacement strategy when the premium is low. All of the other calls expire worthless. Selling the LT $5 puts is a better strategy IMO, but that requires capital, which most people who speculate on calls do not have.
Nice work IMGN execs! Please do let us know if anything positive ever happens there, it's been about 2 years since shareholders had any good news. "Exciting times" more low-priced, free options for the execs!
Apparently shorts have panties in a bunch. They should be very happy, everything is going their way. 2% gain after that 20% loss in a few days is nothing. I guess they were hoping for some sub $5 forced selling follow through.
they will have no trouble attracting top talent to the firm. There are many local people and pharma pros from other large firms that would be attracted to a small high-growth firm.
yes, this has become a huge time sucker for no ROI. I am ready to be done and move on, but I want some ROI for my risk and time before I exit.
I thought you went long, or covered. SGEN is green, but this POS never goes up!
are you suggesting JL is not credible? Blasphemer, where is JDS, the last JL supporter other than the short sellers, BOD and Deerfield, his good friends.
ACAD likely to get pounded today. In a sell off people look for stocks that have gone down less to sell. For those inclined, will likely get to buy this around $20 soon. IMO of course, I hope it goes higher, or gets acquired soon, but market will not help today.
Next support is $10, will probably be there soon at this rate. If a stock can't go up in a bull market...Shareholders must fight for a change in direction and leadership, or a sale.
JDS is brainwashed and a biotech newbie. I once thought the CEO of GNTA Ray Warrell was a genius. Genasense was going to work with (enhance) every cancer drug in nearly all forms of cancer. He told a great story (at least he could communicate and persuade). GNTA's drug did not work, company folded, lesson learned. I am not expecting that here, my point is Jack is not a strong CEO, not even a good CEO because he's not shareholder value focused, not a strong business professional and can't communicate. He also does not hire strong business professionals. Other than that, he's great.
The CFO has a BBA in accounting, no advanced degree, no MBA or Finance degree. Who is the strong business professional making business/financial/shareholder value focused decisions here?
actually, I think it went to about $2. Their reckless CEO spent too much money on plant, land, bulidings...I would take $14 all day long, maybe even $8-10 to get out of this.
If his retirement came with a statement that they have hired an investment banking firm to consider "all options" to max shareholder value, price would be up 50%. If not, maybe 20-25%. ARNA must hire a better business leader. They can take the current bean counter along with Jack; he adds little, or no value and his also highly over-compensated.
Story on FierceBiotech about their cutting some R&D programs. Don't be surprised if ACAD has some products returned soon. If they keep the ACAD collaboration programs, that would be a major + for their outlook.
Jack and the bean counter are clearly not market, or business savvy- example the Deerfield fleecing. Shareholders need to apply pressure for Jack to retire the CEO position.
Hi Sharon. What makes you think Jack is giving up his role as CEO? I doubt he will give up the chairman role, that takes less time, has less responsibility and still makes him some money. If he is to stay involved, this is the better role, they need a business exec to take over as CEO. It might be difficult to find someone strong with Jack as Chairman unless he allows the new CEO the authority to make positive change. If they wait much longer, they might need a turnaround pro.